The invention comprises substituted diazaindole-dicarbonyl-piperazinyl derivatives of general Formula I
wherein:
Q is selected from the group consisting of
-- may represent a bond;
T is —C(O)— or —CH(CN)—; and
—Y— is selected from the group consisting of
compositions thereof and their use for treating HIV infection.
The invention comprises substituted diazaindole-dicarbonyl-piperazinyl derivatives of general Formula I
wherein:
Q is selected from the group consisting of
— may represent a bond; T is —C(O)— or —CH(CN)—; and
—Y— is selected from the group consisting of
compositions thereof and their use for treating HIV infection.